Detalles de la búsqueda
1.
Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation.
PLoS Pathog;
19(8): e1011591, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37585449
2.
A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis.
Hepatology;
2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38652555
3.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer;
154(6): 1043-1056, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994647
4.
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications.
Clin Gastroenterol Hepatol;
22(4): 789-797.e8, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048934
5.
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.
Liver Int;
44(1): 113-124, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37789669
6.
Incidental detection of upper gastrointestinal epithelial neoplasia by screening endoscopy prior to endoscopic ultrasonography in patients with pancreaticobiliary disease.
BMC Gastroenterol;
24(1): 13, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38166726
7.
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Hepatol Res;
2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661715
8.
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.
Hepatol Res;
2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300669
9.
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Hepatol Res;
54(4): 382-391, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37983642
10.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Clin Gastroenterol Hepatol;
21(2): 370-379, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051649
11.
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis.
J Autoimmun;
136: 103027, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996700
12.
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Oncology;
101(4): 270-282, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455517
13.
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
Oncology;
101(10): 624-633, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307798
14.
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
Oncology;
101(9): 542-552, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552968
15.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology;
101(5): 283-291, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657420
16.
Inhibition of integrin binding to ligand arg-gly-asp motif induces AKT-mediated cellular senescence in hepatic stellate cells.
Mol Cell Biochem;
2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37902885
17.
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study.
Hepatol Res;
53(4): 312-321, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36524984
18.
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.
Hepatol Res;
53(6): 489-496, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807720
19.
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.
Hepatol Res;
53(5): 391-400, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707103
20.
Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
Hepatol Res;
53(1): 51-60, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36136893